Class I · High risk Terminated
Dr. King's Natural Medicine Homeopathic Cold Sores & Herpes
Reason Microbial contamination
FDA Drug Recalls
17,898 recalls, newest first
Class I · High risk Terminated
Dr. King's Natural Medicine Homeopathic Regional Allergies Rocky Mtns. U.S.
Reason Microbial contamination
Class I · High risk Terminated
Dr. King's Natural Medicine Homeopathic Regional Allergies Northeastern U.S.
Reason Microbial contamination
Class I · High risk Terminated
Dr. King's Natural Medicine Homeopathic Male Libido
Reason Microbial contamination
Class I · High risk Terminated
Dr. King's Lymph Detox
Reason Microbial contamination
Class I · High risk Terminated
Dr. King's aquaflora Candida High Potency
Reason Microbial contamination
Class II · Moderate risk Terminated
AvKARE Valsartan and Hydrochlorothiazide 320 mg/25 mg tablets 90-count bottle
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
AvKARE Valsartan and Hydrochlorothiazide 320 mg/12.5 mg tablets
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
AvKARE Valsartan and Hydrochlorothiazide 160 mg/25 mg tablets
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
AvKARE Valsartan and Hydrochlorothiazide 160 mg/12.5 mg tablets
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
AvKARE Valsartan and Hydrochlorothiazide 80 mg/12.5 mg tablets
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
Valsartan
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
Valsartan
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
Valsartan HCTZ
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
Valsartan
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
Indomethacin Capsules
Reason Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.
Class II · Moderate risk Terminated
Potassium Citrate Extended-Release Tablets
Reason Failed Tablet/Capsule Specifications: Tablet breakage
Class II · Moderate risk Terminated
Potassium Citrate Extended-Release Tablets
Reason Failed Tablet/Capsule Specifications: Tablet breakage
Class II · Moderate risk Terminated
Unit Dose Valsartan Tablets
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
Unit Dose Valsartan Tablets
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Ongoing
Valsartan and Hydrochlorothiazide Tablets
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Ongoing
Valsartan and Hydrochlorothiazide Tablets
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Ongoing
Valsartan Tablets
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Ongoing
Valsartan Tablets
Reason CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II · Moderate risk Terminated
Eyewash Purified water 98.3%
Reason CGMP Deviations